I-alkylating agent conjugate Archives -

I-ADC Therapeutics SA, i-alkylating agent conjugate, I-antibody eqondiswe ku-CD19, ububanzi bokusabalalisa i-B-cell lymphoma, I-DLBCL, izinga eliphezulu le-B-cell lymphoma, I-B-cell lymphoma enkulu, ILoncastuximab tesirine-lpyl, Zynlonta

I-FDA inikeze imvume esheshayo ye-loncastuximab tesirine-lpyl ye-B-cell lymphoma enkulu

Agasti 2021: I-FDA inikeze i-loncastuximab tesirine-lpyl (i-Zynlonta, i-ADC Therapeutics SA), i-CD19 eqondiswe ku-antibody kanye ne-alkylating agent conjugate, evumela ukusheshiswa kweziguli ezindala ezine-B-cell enkulu ebuyile noma ephikisayo ..

Qala ingxoxo

Skena ikhodi

Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton

Umaka: i-alkylating agent conjugate

Ikhaya / Unyaka Omisiwe

I-ADC Therapeutics SA, i-alkylating agent conjugate, I-antibody eqondiswe ku-CD19, ububanzi bokusabalalisa i-B-cell lymphoma, I-DLBCL, izinga eliphezulu le-B-cell lymphoma, I-B-cell lymphoma enkulu, ILoncastuximab tesirine-lpyl, Zynlonta

I-FDA inikeze imvume esheshayo ye-loncastuximab tesirine-lpyl ye-B-cell lymphoma enkulu

Ulwazi

Ukwelashwa

I-united states

India

China

Iran

Dubai